BNP PARIBAS ARBITRAGE, SA
Position in CRL — Charles River Laboratories International, Inc.
CIK 1166588
NEW YORK, NY
Position in CRL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$43,502,602
+$11,039,227 QoQ
Shares Held
252,189
+55.0% QoQ
Ownership
0.524%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.1530598083183644.ToString("F0")%
Shared 99.84694019168163.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $1,383,399,743 across 39 Diagnostics & Research names. CRL ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
665,128 | $326,930,365 | |
| 2 | DHR |
Danaher Corp /De/
|
1,376,341 | $260,954,253 | |
| 3 | A |
Agilent Technologies, Inc.
|
1,417,666 | $161,585,570 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
66,634 | $84,038,800 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
138,726 | $77,948,752 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
392,886 | $67,002,778 | |
| 7 | DGX |
Quest Diagnostics Inc
|
270,281 | $52,969,670 | |
| 8 | GH |
Guardant Health, Inc.
|
572,650 | $52,895,680 |
All Filings in CRL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,502,602 | 252,189 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $32,463,375 | 162,740 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $17,191,668 | 109,879 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,603,353 | 89,655 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,244,159 | 94,633 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $16,629,321 | 90,083 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,594,311 | 79,171 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $26,407,121 | 127,830 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,193,750 | 67,148 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $10,923,334 | 46,207 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,337,271 | 47,644 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,431,445 | 40,102 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $16,011,995 | 79,338 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,618,314 | 62,498 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,655,401 | 49,062 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $15,154,211 | 70,824 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,875,480 | 17,169 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $13,284,132 | 35,257 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $21,510,836 | 52,126 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $19,093,050 | 51,614 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $6,686,957 | 23,072 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $2,170,783 | 8,688 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $3,585,156 | 15,832 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $1,314,947 | 7,542 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $3,361,350 | 26,633 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||